Patrick Soon-Shiong - Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner at ImmunityBio, Inc.

Issuer-level insider activity

Role
Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
Issuer ticker
IBRX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Patrick Soon-Shiong since 05 Sep 2025

Reported holdings for Patrick Soon-Shiong in ImmunityBio, Inc.

Form 4 holding Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner

ImmunityBio, Inc.

Security class
Common Stock
Shares / value
251,018,873
Estimated value
$497,017,368
Report date
31 Mar 2026
Price
$1.98
Ownership
Indirect
Form 4 holding Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner

ImmunityBio, Inc.

Security class
Common Stock
Shares / value
29,757,911
Estimated value
$58,920,663
Report date
31 Mar 2026
Price
$1.98
Ownership
Direct
Form 4 holding Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner

ImmunityBio, Inc.

Security class
Common Stock
Shares / value
7,976,159
Estimated value
$15,792,794
Report date
31 Mar 2026
Price
$1.98
Ownership
See footnte
Form 4 holding Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner

ImmunityBio, Inc.

Security class
Restricted Stock Units
Shares / value
114,329
Estimated value
$782,010
Report date
22 Feb 2026
Price
$3.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

ImmunityBio, Inc.

Security class
Second Amended and Restated Convertible Promissory Note
Shares / value
$480,000,000
Estimated value
Report date
31 Mar 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

ImmunityBio, Inc.

Security class
Second Amended and Restated Convertible Promissory Note
Shares / value
$480,000,000
Estimated value
Report date
31 Mar 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

ImmunityBio, Inc.

Security class
Second Amended and Restated Convertible Promissory Note
Shares / value
$480,000,000
Estimated value
Report date
31 Mar 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner

ImmunityBio, Inc.

Security class
Second Amended and Restated Convertible Promissory Note
Shares / value
$480,000,000
Estimated value
Report date
31 Mar 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

ImmunityBio, Inc.

Security class
Second Amended and Restated Convertible Promissory Note
Shares / value
$480,000,000
Estimated value
Report date
31 Mar 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Patrick Soon-Shiong in ImmunityBio, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .